KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesDividends payablesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abbott Laboratories (ABT) Work In Process (2016 - 2025)

Abbott Laboratories' Work In Process history spans 17 years, with the latest figure at $904.0 million for Q4 2025.

  • For Q4 2025, Work In Process rose 7.62% year-over-year to $904.0 million; the TTM value through Dec 2025 reached $904.0 million, up 7.62%, while the annual FY2025 figure was $904.0 million, 7.62% up from the prior year.
  • Work In Process for Q4 2025 was $904.0 million at Abbott Laboratories, down from $961.0 million in the prior quarter.
  • Across five years, Work In Process topped out at $962.0 million in Q2 2025 and bottomed at $680.0 million in Q4 2022.
  • The 5-year median for Work In Process is $823.5 million (2023), against an average of $816.2 million.
  • The largest annual shift saw Work In Process increased 25.69% in 2021 before it decreased 10.8% in 2022.
  • A 5-year view of Work In Process shows it stood at $694.0 million in 2021, then dropped by 2.02% to $680.0 million in 2022, then increased by 18.68% to $807.0 million in 2023, then increased by 4.09% to $840.0 million in 2024, then increased by 7.62% to $904.0 million in 2025.
  • Per Business Quant, the three most recent readings for ABT's Work In Process are $904.0 million (Q4 2025), $961.0 million (Q3 2025), and $962.0 million (Q2 2025).